SEC Filing Summary: Medasorb Technologies Corporation (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medasorb Technologies Corporation (not Cytosorbents Corp) on April 12, 2007, covering the event date of April 9, 2007. The company is incorporated in Nevada and is based in Monmouth Junction, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
Effective April 9, 2007, Dr. Edward R. Jones, M.D., MBA, was appointed to the Board of Directors. Dr. Jones is an attending physician at Albert Einstein Medical Center and Chestnut Hill Hospital and a Clinical Professor of Medicine at Temple University Hospital. He has published over 30 works on kidney-related illnesses and is a sixteen-year member of the Renal Physicians Association. He is scheduled to become the President of the Renal Physicians Association in 2009.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, specific risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the company name is Medasorb Technologies Corporation, not Cytosorbents Corp.
- Confirm the effective date of Dr. Edward R. Jones' board appointment (April 9, 2007).
- Review Dr. Jones' professional background in nephrology and his upcoming role as President of the Renal Physicians Association.
- Note that this filing contains no financial performance data.